Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689013 · ClinicalTrials.gov registry record · NA
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
NCT00689013: Completed NA study, sponsored by University of Tennessee.
NCT00689013 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 205 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00689013, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.
Interventions
- OTHER Personalized letter
- OTHER Flyer advertisement
- OTHER Newspaper press release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-03 |
| Phase | NA |
What the finished NCT00689013 record still lists
NCT00689013 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Personalized letter is the first listed.
NCT00689013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00689013 about?
NCT00689013 is a clinical study titled "The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting". The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.
What is the current status of trial NCT00689013?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2008-02. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00689013?
The interventions under investigation include: Personalized letter (OTHER), Flyer advertisement (OTHER), Newspaper press release (OTHER).
Who is sponsoring clinical trial NCT00689013?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00689013's enrollment target sits among peer trials
205 499th of 2000 higher than 1,501 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia